1 Min Read
Nov 2 (Reuters) - KARO PHARMA AB:
* Q3 NET SALES SEK 137.1 MILLION VERSUS SEK 85.2 MILLION YEAR AGO
* Q3 EBITDA SEK 34.0 MILLION VERSUS SEK 10.2 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.